Brief: Virios Therapeutics Announces Q4, FY 2021 Financial Results
17/03/2022 11:16
March 17 (Reuters) - Virios Therapeutics Inc VIRI.O :
* VIRIOS THERAPEUTICS ANNOUNCES FOURTH QUARTER AND FULL YEAR
2021
FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
* Q4 LOSS PER SHARE $0.54
* CASH ON HAND OF $14.0 MILLION ON DECEMBER 31, 2021,
PROVIDES
RUNWAY THROUGH Q1 2023
Source text for Eikon: ID:nBw3K09MPa
Further company coverage: VIRI.O
Recent news on Dogwood Therapeutics
See all newsDogwood Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Dogwood Therapeutics Q2 net loss widens on higher costs, impairment charge
Brief: Dogwood Therapeutics Q2 EPS USD -0.34
Dogwood Therapeutics Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Dogwood Therapeutics Announces Commencement Of Halneuron® Chemotherapy Induced Neuropathic Pain Phase 2B Long Term Extension Study